One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their ...

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

Britain’s pharmacists have called for tougher regulation of weight-loss drugs after reports showed some online sellers have ...

Novo Nordisk A/S rose the most since August 2023 after its experimental shot delivered as much as 22% weight loss in an early ...

The National Pharmacy Association (NPA) has written to regulators calling for tougher rules over access to medications like ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common ...

The National Pharmacy Association is calling for tougher rules in the market, saying people with a history of eating ...

Pharmacists say they are aware of people being wrongly prescribed the drugs who have previously had eating disorders, or ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...